| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/10/2011 | US20110034499 Spiroindolines as modulators of chemokine receptors |
| 02/10/2011 | US20110034495 Method of Modulating Stress-Activated Protein Kinase System |
| 02/10/2011 | US20110034487 Cxcr3 antagonists |
| 02/10/2011 | US20110034485 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
| 02/10/2011 | US20110034482 Amine salts of a crth2 antagonist |
| 02/10/2011 | US20110034480 Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti-inflammatory and the use thereof for the treatment of respiratory disorders |
| 02/10/2011 | US20110034466 Novel five-membered ring compound |
| 02/10/2011 | US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034457 Pyridothiophene Compounds |
| 02/10/2011 | US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034454 Morpholino pyrimidine derivatives and their use in therapy |
| 02/10/2011 | US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034451 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034448 Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034434 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 02/10/2011 | US20110034424 Method for the long term nsaid use |
| 02/10/2011 | US20110034422 Dendrimers for sustained release of compounds |
| 02/10/2011 | US20110034417 Substituted piperidine compounds and methods of their use |
| 02/10/2011 | US20110034407 Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota |
| 02/10/2011 | US20110033556 Natural Pharmaceutical Preparations for Increasing Albumin |
| 02/10/2011 | US20110033545 Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
| 02/10/2011 | US20110033539 Compositions and methods for preparing and using same |
| 02/10/2011 | US20110033537 Sustained Drug Release Composition |
| 02/10/2011 | US20110033527 Opthalmic compositions of cyclosporin |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033512 Personal care composition with improved spreadability |
| 02/10/2011 | US20110033506 Combination dosage form of low-dose modafinil and low-dose sildenafil |
| 02/10/2011 | US20110033486 Gene expression markers for crohn's disease |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033451 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | CA2806790A1 Composition and method for oral delivery of cobra venom |
| 02/10/2011 | CA2770194A1 Sphingosine-1-phosphate receptor agonists |
| 02/10/2011 | CA2769563A1 Novel compounds as modulators of glucocorticoid receptors |
| 02/10/2011 | CA2769347A1 Methods for treatment of pain |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281813A1 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281571A2 Outer membrane vesicle (omv) vaccine comprising n. meningitidids serogroup b outer membrane proteins |
| 02/09/2011 | EP2281570A2 Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281565A2 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2281558A1 Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors |
| 02/09/2011 | EP2281008A2 Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
| 02/09/2011 | EP2280995A2 Methods for treating inflammation |
| 02/09/2011 | EP2280986A2 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/09/2011 | EP2280952A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
| 02/09/2011 | EP2280946A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 02/09/2011 | EP2280719A2 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
| 02/09/2011 | EP2280718A1 Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection |
| 02/09/2011 | EP2280712A2 Fluocinolone formulations in a biodegradable polymer carrier |
| 02/09/2011 | EP2280707A1 Alpha2b and alpha2c agonists |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | CN1939417B Medicinal composition of douricine, tinosporae or its extract |
| 02/09/2011 | CN1827638B Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 02/09/2011 | CN1726914B Slow release tablet of rotundine and production process |
| 02/09/2011 | CN1547464B Prolonged release bioadhesive therapeutic systems |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970401A Leukotriene b4 inhibitors |
| 02/09/2011 | CN101970052A Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 02/09/2011 | CN101969956A Corticosteroid compositions |
| 02/09/2011 | CN101969950A Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation |
| 02/09/2011 | CN101969945A Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/09/2011 | CN101969939A Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 02/09/2011 | CN101967153A Metabolite of 10-O-(dimethylamino ethyl) ginkgolides B and medicinal composition containing same |
| 02/09/2011 | CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967113A 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof |
| 02/09/2011 | CN101967104A IV type crystal, method for preparing the same and pharmaceutical composition comprising the same |
| 02/09/2011 | CN101966323A Compound common andrographis herb injection for treating high fever of pigs and preparation method thereof |
| 02/09/2011 | CN101966316A Gujin pill pellet and preparation method thereof |
| 02/09/2011 | CN101966304A Medicament for freeing network vessels and activating blood and preparation method thereof |
| 02/09/2011 | CN101966298A Traditional Chinese medicine for treating wind-cold numbness |
| 02/09/2011 | CN101966266A Chinese medicinal herb health-care pad for postoperative care |
| 02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
| 02/09/2011 | CN101966243A Method for preparing total anthraquinones of Indian damnacanthus herb |
| 02/09/2011 | CN101966240A Medicament for treating infant unknown fever |
| 02/09/2011 | CN101966238A Medicament for treating sciatica and preparation method thereof |
| 02/09/2011 | CN101966237A Medicament for treating paralysis and preparation method thereof |
| 02/09/2011 | CN101966229A Judging method for effective ingredients of asiatic moonseed rhizome |
| 02/09/2011 | CN101966147A Ibuprofen injection composite and preparation method thereof |
| 02/09/2011 | CN101966125A Thermosensitive moxibustion moxa stick capable of efficiently stimulating meridian qi transmission and preparation method thereof |
| 02/09/2011 | CN101417080B Traditional Chinese medicine preparation for treating rheumatic heart disease |
| 02/09/2011 | CN101348433B 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
| 02/09/2011 | CN101341916B Cold tea for nourishing stomach |
| 02/09/2011 | CN101336993B External tincture for treating wind-dampness arthralgia and urgent sprain and preparation method thereof |
| 02/09/2011 | CN101322727B Exterior patch for freeing collateral vessels and dispelling pain and producing method thereof |